M

Maccura Biotechnology Co Ltd
SZSE:300463

Watchlist Manager
Maccura Biotechnology Co Ltd
SZSE:300463
Watchlist
Price: 13.84 CNY -4.95% Market Closed
Market Cap: 8.5B CNY
Have any thoughts about
Maccura Biotechnology Co Ltd?
Write Note

Maccura Biotechnology Co Ltd
Unrealized Security Profit/Loss

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Maccura Biotechnology Co Ltd
Unrealized Security Profit/Loss Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Unrealized Security Profit/Loss CAGR 3Y CAGR 5Y CAGR 10Y
M
Maccura Biotechnology Co Ltd
SZSE:300463
Unrealized Security Profit/Loss
ÂĄ12.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Unrealized Security Profit/Loss
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Unrealized Security Profit/Loss
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Unrealized Security Profit/Loss
-ÂĄ134.5m
CAGR 3-Years
-269%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Unrealized Security Profit/Loss
ÂĄ6.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
W
WuXi XDC Cayman Inc
HKEX:2268
Unrealized Security Profit/Loss
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Maccura Biotechnology Co Ltd
Glance View

Market Cap
8.5B CNY
Industry
Life Sciences Tools & Services

Maccura Biotechnology Co., Ltd. engages in the research, development, production, sale, and service of in vitro diagnostic products. The company is headquartered in Chengdu, Sichuan and currently employs 2,901 full-time employees. The company went IPO on 2015-05-28. The firm provides hundreds of products which cover clinical biochemistry, chemiluminescent immunoassay, rapid diagnosis, thrombosis, hemostasis, and molecular diagnosis.

Intrinsic Value
13.67 CNY
Overvaluation 1%
Intrinsic Value
Price
M

See Also

What is Maccura Biotechnology Co Ltd's Unrealized Security Profit/Loss?
Unrealized Security Profit/Loss
12.5m CNY

Based on the financial report for Sep 30, 2024, Maccura Biotechnology Co Ltd's Unrealized Security Profit/Loss amounts to 12.5m CNY.

Back to Top